Multisite monitoring of choline using biosensor microprobe arrays in combination with CMOS circuitry by Frey, Olivier et al.
DOI 10.1515/bmt-2012-0098      Biomed Tech 2014; 59(4): 305–314
Olivier Frey*, Jörg Rothe, Flavio Heer, Peter D. van der Wal, Nico F. de Rooij and Andreas 
Hierlemann
Multisite monitoring of choline using biosensor 
microprobe arrays in combination with CMOS 
circuitry
Abstract: A miniature device enabling parallel in vivo 
detection of the neurotransmitter choline in multiple 
brain regions of freely behaving rodents is presented. This 
is achieved by combining a biosensor microprobe array 
with a custom-developed CMOS chip. Each silicon micro-
probe comprises multiple platinum electrodes that are 
coated with an enzymatic membrane and a permselective 
layer for selective detection of choline. The biosensors, 
based on the principle of amperometric detection, exhibit 
a sensitivity of 157 ± 35 µA mM-1 cm-2, a limit of detection of 
below 1 µM, and a response time in the range of 1 s. With 
on-chip digitalization and multiplexing, parallel record-
ings can be performed at a high signal-to-noise ratio with 
minimal space requirements and with substantial reduc-
tion of external signal interference. The layout of the inte-
grated circuitry allows for versatile configuration of the 
current range and can, therefore, also be used for func-
tionalization of the electrodes before use. The result is a 
compact, highly integrated system, very convenient for 
on-site measurements.
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Introduction
With the continuous growth of worldwide neurosci-
ence research activities, a trend toward addressing more 
difficult biological questions can be observed [7, 20]. This 
is, on the one hand, a consequence of the highly complex 
nature of the central nervous system and, on the other 
hand, due to the availability of more advanced technol-
ogy and fabrication processes, especially in microtechnol-
ogy. Miniature tools for direct interaction with neuronal 
cells and tissue at single-cell and subcellular length scales 
become more and more pervasive [21, 34, 40].
Although wire microelectrodes with a single record-
ing site at the tip still may constitute the dominant experi-
mental method for electrophysiological recordings [11], 
several groups start to employ microfabricated probe 
technology, in which multiple microelectrodes can be 
integrated on a single probe shank that then access mul-
tiple brain sites in parallel at relatively low tissue damage 
[5, 9, 14, 17, 30]. Arrays of such microprobes and electrodes 
can be precisely arranged in two or three dimensions, ena-
bling a spatially highly resolved mapping of in vivo neural 
circuitry and interpretation of network-related phenom-
ena [1, 2, 8, 23, 26, 32]. Multisite recordings have also been 
performed with wire arrays; however, their assembly is, in 
most cases, limited in precision and number of electrodes, 
as they are assembled manually [37, 41].
In brain tissue, neurochemically active molecules 
are central for intercellular communication, and their 
monitoring is highly important for understanding brain 
functions and their relevance with respect to neural dis-
eases such as epilepsy, Alzheimer’s disease, and Parkin-
son’s disease [15]. The neurotransmitter acetylcholine, for 
example, is highly involved in cognitive processing and 
attention in the central nervous system. It is important 
for synaptic plasticity and is associated with a variety of 
behavioral aspects, such as motivation and reward [12, 13].
Biosensors offer the possibility to monitor several neu-
rotransmitters at suitable temporal resolution. Choline, 
the breakdown product of freshly released acetylcholine, 
can be detected via the enzyme choline oxidase, which 
catalyzes the oxidation of choline to betaine and hydro-
gen peroxide (H2O2). H2O2, in turn, can be electrochemi-
cally oxidized at the surface of a platinum (Pt) electrode, 
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providing a current that is directly proportional to the 
choline concentration. Good spatial resolution can be 
achieved by direct immobilization of the used enzymes on 
top of the microelectrodes.
Several groups have presented such biosensors in the 
past years. Many of these sensors are based on insulated 
Pt wires or carbon fibers that are exposed at the tip to 
create a disc or cylinder microelectrode [19, 24, 27, 28, 31, 
35, 38]. Enzyme coating is either performed by dip coating 
[19, 24, 27] or by dispensing small amounts of enzyme 
solution over the active electrode area [31, 38]. Further-
more, electrochemical deposition methods with a variety 
of polymers have been used [28, 35]. They allow for better 
spatial control, and tedious serial deposition of several 
electrodes has been replaced by a parallel coating of only 
targeted and biased electrodes.
Recently, enzyme electrodes have also been integrated 
on microfabricated probes carrying multiple electrodes 
[5, 6, 25, 39]. The utilized functionalization methods are 
similar to previously used single-electrode functionaliza-
tion methods (drop/dip coating) and are thus limited in 
upscaling to larger multielectrode ensembles.
Looking at the technological developments, the appli-
cations under investigation, and the requests of the neu-
roscience community, two trends become evident:
(a) Use of arrays of implantable biosensors for monitoring 
of neurotransmitters in different brain areas in parallel
(b) Conduction of trials and recordings in freely behaving, 
task-performing animals in order to correlate 
concentration variations of specific neurotransmitters 
to observable behavior.
Both trends entail stringent technology requirements [4]. 
Precise fabrication of microelectrode arrays is crucial for 
accurate positioning and definition of the inter-electrode 
spacing. Reliable functionalization protocols for multi-
ple microelectrodes to create biosensor arrays have to be 
developed, as well as electrochemical setups capable of 
acquiring many signals in parallel featuring the needed 
performance and reliability. Array compatibility of the 
microelectrode fabrication and biosensor functionaliza-
tion procedures, as well as multiple signal acquisition, 
are mandatory prerequisites. Furthermore, noise reduc-
tion techniques to enable low analyte detection limits and 
small overall device dimensions in order to not impede 
the animal during experiments are important issues.
We recently developed a biosensor microprobe array 
[17], based on silicon microfabrication, and the cor-
responding array-compatible electrode functionaliza-
tion techniques through electrochemical methods. Our 
next step included combining this array with a CMOS 
Figure 1 Layout of the microprobe comb consisting of four identical 
shanks of 6.5 mm length, each comprising two recessed 50 μm ×  
150 μm working electrodes (zoomed view) and one 40 μm × 500 μm 
electrode, used either as reference or counter electrode.
Cross-sections AA′ and BB′ show the layer structures at the 
recessed electrode and pad site, respectively.
(complementary metal oxide semiconductor) chip that 
has been developed in our laboratory and that hosts cir-
cuitry for performing electrochemical experiments, as 
well as on-chip analog-to-digital conversion. With the 
overall system packaged in a compact and flexible way, it 
can be mounted directly on a rodent’s head and features a 
minimum of cable connections even for many electrodes 
due to on-chip integrated multiplexing circuitry. This 
technological approach constitutes a step toward three-
dimensional neurochemical mapping of local brain areas.
Materials and methods
Silicon microprobes
The microprobe array has a comblike design, consisting of 
four parallel, identical shanks at 550 µm pitch, featuring 
a length of 6.5  mm and a cross-sectional area of 40 µm ×  
100 µm (Figure 1). Each shank comprises two Pt microelec-
trodes, located at 500 µm distance from the tip and featuring 
an area of 50 µm × 150 µm. Both electrodes are recessed by 
10 µm in order to create a small compartment that protects 
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the biosensitive membrane during tissue insertion and 
removal. The distance between the electrodes is 200 µm. 
On each shank, a larger, 40 µm × 500 µm, non-recessed elec-
trode, located in the middle of the shank, can be used either 
as pseudo-reference or a counter electrode. When used as a 
reference electrode, the Pt layer is electrochemically covered 
with a 5-µm-thick silver layer that is partially transformed 
into AgCl. The present geometry of the comb has been 
chosen to target the medial prefrontal cortex of a rat’s brain.
The microprobe arrays have been fabricated using 
standard micromachining techniques on 4-in., 300-µm-
thick silicon wafers. Potassium hydroxide (KOH) wet 
etching has been used to create the recesses of the 
working electrodes. This has the advantage that the inter-
connection lines can be laid across the inclined side walls 
appearing during the KOH etch. The substrate is insulated 
(bottom passivation) with, first, a 200-nm-thick layer 
of thermal silicon oxide and, second, by a deposition of 
200 nm of low-pressure chemical vapor deposited (LPCVD) 
silicon nitride. A 130-nm Pt with a 20-nm tantalum adhe-
sion layer has been deposited by using e-beam evapora-
tion and structured by means of a lift-off process. The top 
passivation consists of 200-nm LPCVD silicon nitride that 
has been removed at the electrode and contact pad sites 
through reactive ion etching to expose the underlying Pt. 
The microprobe has been shaped with two deep reactive-
ion etching steps. First, the wafer has been thinned from 
the backside to the intended shank thickness (40 µm). 
Second, the contours of the microprobes have been etched 
from the front side, which released them from the bulk. 
Small joints are retaining the microprobe combs in the 
wafer grid, where they are stored and can then be released 
immediately before use (for further details and figures of 
each individual step, refer to ref. [17]).
CMOS chip
The schematic of the device and its electrochemical princi-
ple are depicted in Figure 2. An external master potentiostat 
controls the voltage difference between the reference elec-
trode and all working electrodes. The electrochemically 
generated current on each individual working electrode is 
measured in parallel using CMOS integrated circuitry.
The CMOS chip has been fabricated in an industrial 
0.6-µm, 5-V 3M2P CMOS process (X-FAB, Erfurt, Germany) 
and has been previously presented in detail [22, 29]. It 
comprises 24 current read-out channels, eight of which are 
used for the microprobe comb to simultaneously record 
from the eight integrated working electrodes. The current 
measurement scheme is based on a very compact sigma-
delta converter. It makes use of the double-layer capaci-
tance of the electrode-electrolyte interface to integrate the 
charge. The potential of the electrode is kept at a certain 
voltage by adding or subtracting charge from the double-
layer capacitance with the precharged reference capacitor 
CRef. The amount of charge that is delivered per time is the 
current that flows through the working electrode.
The converter circuit features very low noise, and the 
full-scale current range, IFS, can be set by changing the 
sampling frequency, fs, the reference capacitance, CRef, and 
the reference voltage, VRef, which is used to charge CRef:
IFS = ± CRef×VRef×fs.
Figure 2 Schematic and photograph of the implantable microprobe device.
The CMOS chip and master potentiostat are assembled and electrically interconnected on a custom-made, flexible PCB. Non-transparent 
epoxy glue is used to protect the wires and the light-sensitive CMOS chip.
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The large adjustable range, IFS, allows, on the one 
hand, for recording of very low currents in the measure-
ment mode, and, on the other hand, for application of 
large currents for electrochemical depositions on the 
electrodes.
Device packaging and setup
A custom-designed printed circuit board (PCB) hosts a 
CMOS chip, a microprobe comb, and additional electri-
cal components for the master potentiostat. The PCB has 
a flexible front part allowing for vertical implantation of 
the microprobe comb into the brain and flat position-
ing and fixation of the electronic part on the animal’s 
skull by using dental acrylic glue and fixation bolts. 
This results in a compact assembly on the animal’s 
head with minimal disturbance for the animal while 
performing the experimental task. The CMOS chip is 
glued on the top of the PCB and wire bonded. On the 
bottom, two operational amplifiers (AD8539, Analog 
Devices, Norwood, MA, USA), two resistors (1 MΩ), and 
two capacitors (100 nF, 10 µF) for electrical decoupling 
form the master potentiostat, which holds the bulk at a 
defined potential controlled by the reference electrode. 
All parts are encapsulated in non-transparent epoxy 
glue for electrical and mechanical protection. On the 
backend of the device, a zero-insertion-force connector 
can be connected for electronic control and data acqui-
sition. VSet defines the potential difference between the 
reference electrode and all working electrodes.
A thin, flexible cable is used to connect the device to 
a field-programmable gate array (FPGA) module for chip 
control and data processing (Figure 3). The FPGA per-
forms filtering and decimating of the output signals of the 
sigma-delta modulators to yield high-resolution signals. 
Therefore, two filters have been implemented, a cascaded 
integrator-comb filter, used as a first filter stage, and an 
exponential moving average filter as a second stage. 
The FPGA is connected via USB to a conventional laptop 
running Labview that records the measurement data and 
supplies power to the system.
Electrode functionalization
The biosensor principle is based on amperometric detec-
tion of peroxide using an enzymatic membrane, deposited 
on a Pt microelectrode. For the detection of choline, the 
enzyme choline oxidase from Alcaligenes sp. (ChoOx, EC 
1.1.3.17) has been used and immobilized on the Pt surface 
by electrochemically aided adsorption. Briefly, the whole 
array has been immersed into a freshly mixed deposition 
solution comprising the enzyme, the protein albumin from 
bovine serum (BSA), and the cross-linker glutaraldehyde 
(all from Sigma Aldrich, Switzerland). The application 
of  a sequence of electrical potentials (25 times 1.8 V vs. 
Ag/AgCl) increases the protein concentration at the biased 
electrode, which initiates a local cross-linking and the for-
mation of gelatinous membrane containing ChoOx. The 
detailed deposition protocols have already been described 
elsewhere [17]. Here, they have been applied without any 
external potentiostat but by directly using the integrated 
circuitry. Owing to the high deposition potential used, 
the current range of the sigma-delta converters has been 
set to IFS = ± 58.9 µA (CRef = 10 pF, VRef = ± 1.9 V, fs = 3.1 MHz). 
For the deposition, an external Pt wire and Ag/AgCl wire 
have been used for the counter and reference electrodes, 
respectively. The adhesion of the membrane to the elec-
trode surface has been improved by a coating of (3-ami-
nopropyl)triethoxysilane (Sigma) via vapor silanization 
before deposition.
Subsequently, m-polyphenylenediamine (m-PPD, 
Sigma) has been electropolymerized on the micro-
electrodes by cyclic voltammetry (20 cycles, 0–0.9 V vs. 
Ag/AgCl, 50 mV/s) and used as permselective layer to sub-
stantially reduce interference signals from other electro-
active species such as dopamine (DA) and ascorbic acid 
(AA). Also present in the extracellular fluid of the brain, 
they are oxidized at a similar potential as used for the 
Figure 3 Schematic and photograph of the FPGA module and laptop controlling the device.
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detection of H2O2. The integrated circuits of the CMOS chip 
have been used for potential cycling with following set-
tings: CRef = 1 pF, VRef = ± 1.0 V, fs = 1 MHz, i.e., IFS = ± 1.0 µA.
As both deposition procedures rely on electrochemi-
cal principles, they can be spatially controlled and can be 
executed in parallel on multiple electrodes of the array. In 
general, the microelectrodes closer to the tip (xf in Figure 
4) on each shank are coated with an enzyme membrane. 
On the adjacent electrodes (xb), an “inactive” BSA-pro-
tein-only membrane is deposited. The latter is used as 
a control or “null” sensor in a differential measurement 
mode. The protein membrane is required to match the dif-
fusion properties of the sensitive microelectrodes.
After functionalization, the devices are stored dry at 
4°C.
Electrochemical recording setup
Calibration measurements have been conducted in 50  ml 
phosphate-buffered saline solution at either 37°C or room 
temperature (22–25°C). The liquid has been continuously 
stirred using a standard magnetic stirrer. No Faraday cage 
was used. Small volumes of choline, DA, and AA stock solu-
tions have been added manually at constant time inter-
vals to obtain defined analyte concentrations. It has been 
assumed that homogenous dissolution is achieved in less 
than a second. All eight working electrodes have been polar-
ized at 0.65 V using the probe-integrated thin film Ag/AgCl 
reference and Pt counter electrodes. The current range has 
been set to IFS = ± 2.5 nA (CRef = 0.1 pF, VRef = ± 0.1 V, fs = 250 kHz).
Recordings in agarose gel (1%) have been performed 
at room temperature with the same electrochemical set-
tings. The biosensor electrodes have been placed 5  mm 
below the surface using a micromanipulator. The tip of a 
glass micropipette filled with 200 µM colored choline solu-
tion has been positioned at a distance of ~300 µm from 
electrode 4a (see top view in Figure 7) by using a second 
micromanipulator. Collinear insertion and slow injection 
rates ( < 100 nl/min) are important to avoid cracks in the 
gel, which would lead to inhomogeneous, non-spherical 
choline diffusion.
Results and discussion
Device characteristics and functionality
The used microfabrication processes allowed for precise 
and reproducible fabrication of the microprobe arrays 
Figure 4 Photograph of the microprobes with functionalized 
electrodes.
The front electrodes (xf) are covered with a choline oxidase enzyme 
membrane. The back electrodes (xb) do not comprise any active 
enzyme but a slightly larger amount of the BSA protein only. On all 
electrodes, front and back, an additional interference rejection layer 
(m-PPD) has been deposited (schematics).
with  ± 2 µm accuracy with respect to the designed masks. 
Straight and smooth shanks with a very sharp tip reduce 
tissue damage and brain surface deformation during 
implantation (see Figure 4 and ref. [17]). The same process 
can be used for future layouts that are different in shank 
number and length, as well as in the number and posi-
tion of the microelectrodes on each shank, and targeted 
at specific brain regions in different experimental setups. 
Besides such rigid microprobes, other groups have pre-
sented flexible constructs that may better match the 
mechanical properties of the soft brain tissue [10, 33, 36]. 
Sufficient long-term biocompatibility has been observed; 
however, precise electrode positioning may be more 
difficult.
The quality of the Pt electrodes has been assessed 
electrochemically. Figure 5 shows an overlay of 10 con-
secutively recorded cyclic voltammograms (CVs) of all 
eight microelectrodes. All CVs have been recorded in par-
allel in 1 M de-aerated H2SO4 in the potential window of 
-0.42 to 1.20 V versus the shank-integrated Ag/AgCl refer-
ence electrode at 100 mV/s. Adequate Pt electrode quality 
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and reproducibility is demonstrated, and a high current/
voltage resolution of the CMOS circuitry is evident, as 
clearly resolved single peaks in the hydrogen region are 
visible on all eight electrodes. The roughness factor (effec-
tive surface/geometric surface) of the Pt electrode is 1.1 
(8200 µm2/7500 µm2) and compares well to previous pub-
lications [16, 17]. It has been calculated by the measured 
charge associated with a 100% hydrogen coverage, which 
corresponds to the positive region between -0.42 to 0.00 
V (shaded area AC in Figure 5) upon assuming 210 µC/cm2 
charge transfer [3]. CVs have been measured before every 
microelectrode functionalization for the purpose of elec-
trochemical cleaning of the electrodes and for controlling 
the Pt quality, to check on inter-electrode cross-talk and to 
assess the general electrical functionality of each channel.
The CMOS chip has a power consumption of 25 ± 5 mW. 
Its small size of 6.5 mm × 3.0 mm allows for construction of 
a small head stage, suitable for freely behaving animals. 
More important, electrochemical signals of many elec-
trodes are digitized on-chip, making it less susceptible to 
external interferences such as electromagnetic fields or 
cable distortions. Linearity and electrical noise within the 
smallest current range allow for resolving currents below 
0.5 pA. While the use of CMOS technology allowed for a 
substantial miniaturization of the signal acquisition part, 
the overall size reduction of the head stage is, currently, 
on the one hand, limited by the PCB that is required to 
Figure 5 Ten consecutive CVs of each electrode in 1 M de-aerated 
H2SO4 (-0.42 to 1.20 V vs. Ag/AgCl, 100 mV/s).
Curves have been recorded in parallel using eight current read-out 
channels of the CMOS chip (curves are offset for better visibility).
connect to the CMOS chip via wire bonds and, on the other 
hand, by the size of the cable connector, which has to be 
robust and reliable during experiments. The whole setup 
including the FPGA module and laptop is very compact 
and therefore very convenient for field experiments.
Biosensing characteristics and application
Figure 4 shows a photograph of the eight coated micro-
electrodes. Membranes of the same type (enzyme vs. BSA 
membranes) have been deposited in parallel. The picture 
shows identical and spatially well-controlled depositions 
on all electrodes with minimal unspecific adsorption on 
the shank. The larger electrodes in the middle of shanks 
1 and 2 have been used as integrated Ag/AgCl reference 
electrodes. The Ag/AgCl layer nicely covers the underlying 
Pt. A potential of +68.4 ± 0.8 mV (n = 6) versus a standard 
liquid-phase Ag/AgCl reference electrode (3 M KCl) was 
reproducibly measured in PBS (pH 7.2).
Raw data of simultaneously recorded in vitro current 
response curves of a calibration measurement of all 
choline biosensors are presented in Figure 6A. The elec-
trodes have been functionalized as depicted in Figure 4. 
The measurement was performed 1 day after membrane 
deposition. For better visibility, the single recorded curves 
have been offset. “xf” and “xb” denote the signals of the 
active and inactive electrodes, respectively. “xf-xb” shows 
the differential curves, with the inactive electrode signals 
being subtracted. The biosensors show good reproducibil-
ity of all electrodes with respect to sensitivity and selectiv-
ity. Active biosensor electrodes instantaneously respond 
to 10 µM choline injections, which correspond to concen-
trations expected in the extracellular fluid of a rat brain. 
The sensitivity was determined to be 11.8 ± 2.6 pA/µM, cor-
responding to 157 ± 35 µA mM-1 cm-2 (n = 35) with a linear 
range up to 100 µM (Figure 6B). The standard deviation 
reflects the sensitivity variation obtained by using biosen-
sors of different deposition runs and different fabrication 
batches. The m-PPD layer efficiently blocks DA and AA. 
The choline signal is not altered owing to the presence 
of DA and AA in the PBS solution. In some cases, a small 
increase in current is visible for DA or AA on the active 
electrode (xf). When diffusion and rejection properties 
are comparable for both electrodes, a similar contribution 
is also observed on xb and can be effectively removed by 
using the differential method (xf-xb). The rejection char-
acteristics of xf and xb, however, are not always the same, 
but have to be adjusted by proportional scaling of the 
signals on the basis of the differences in the recorded cali-
bration curves. If the difference between corresponding 
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electrodes, xf and xb, is  > 20%, biosensors are not used. 
Owing to the parallel nature of the deposition process, 
the inter-electrode variability of the response to choline 
is as low as 6.9 ± 4.6% (n = 10, with n being the number of 
microprobe arrays), which represents the relative stand-
ard deviation calculated from the standard deviations of 
the sensitivities of the four biosensors of each of the 10 
microprobe arrays. Thus, biosensor sensitivities within a 
device vary by 7% on average. In some cases, we observed 
a small cross-talk ( < 5%) between adjacent electrodes (xf 
and xb). As this cross-talk was not consistent, we assume 
the reasons to be cross-contamination during deposition 
or electrical cross-talk. The temperature dependence was 
measured to be 0.3 ( = 2.75%) pA µM-1 °C-1 (n = 4).
The differential method significantly reduces the noise 
level to  < 1 pA (peak-to-peak) in PBS, and to 3 pA at a choline 
concentration of 20 µM (Figure 6C). This results in a limit of 
detection of 0.25 and 0.8 µM, respectively (three times the 
background). It has to be mentioned here that the experi-
ment was carried out on a conventional laboratory bench 
without Faraday cage. Neither magnetic stirring nor differ-
ent manipulations of the experimenter influenced the noise 
level, demonstrating the benefit of the circuitry integration.
Figure 6D shows the fast response time of the bio-
sensor, which is on the order of 1 s. However, it is highly 
dependent on the method used for changing the choline 
concentration in the solution and may be even smaller 
when using a flow injection system. Further character-
istics, such as biosensor shelf lifetime and interference 
rejection rates over time, can be found in refs. [17, 18].
One micromolar of peroxide produced a current 
signal of 24.9 pA (not shown in the graph). Considering 
that ChoOx produces two molecules of H2O2 per choline 
molecule, an efficiency of about 20% can be calculated, 
which gives an indication on the enzyme load and elec-
tro-oxidation efficiency of H2O2. It further shows that the 
ChoOx-mPPD membrane has a good H2O2 permeability.
The usability of such a multielectrode configuration is 
illustrated in Figure 7A. Colored choline solution (200 nl) 
has been injected in the vicinity of the fourth shank, 
inserted in agarose gel (1%), which has been used here as 
a brain-mimicking substrate. While the expected spheri-
cal diffusion can be observed optically, the four biosen-
sors are responding according to their location relative to 
the injection site. Figure 7B shows the derived concentra-
tion distributions at ti[s] = t0+i × 100 s for i = {1,…,7}.
Figure 6 (A) Simultaneously recorded response curves (raw data) of calibration measurements in PBS at 37°C. Aliquots of choline and the 
two main interferents, DA and AA, were consecutively added to reach concentrations that can be expected in the extracellular fluid in the 
brain. “xf-xb” denote differential curves. (B) Calibration curve. (C) Close-up views (scaled with respect to the current axis) of curve 1f–1b at 
two different positions to demonstrate noise levels, and (D) close-up view of curve 1f (scaled with respect to time) to illustrate the response 
time. [Boxes indicating close-up views in (A) are not to scale for better visibility.]
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Conclusion
The presented device is based on microelectrode fabri-
cation and dedicated electrode functionalization so that 
truly simultaneous multisite neurochemical recording in 
freely behaving animals becomes possible. It has been 
realized by combining silicon-micromachined multishank 
probes with a versatile CMOS chip offering electrochemi-
cal functionality.
Silicon microfabrication technologies allow for 
precise and custom-designed fabrication of microprobes 
of almost any desired shape and number, which can be 
equipped with multiple microelectrodes. Functionali-
zation of these microelectrodes requires a reproducible 
and array-compatible method, i.e., a method that can be 
spatially controlled and is preferably parallel. Therefore, 
electrochemistry-based methods have been used for elec-
trode cleaning, enzyme immobilization, and deposition 
of the anti-interference layer. The electrochemical proto-
cols have been executed directly with the CMOS circuitry 
and do not require any additional equipment. This has 
become possible by the implementation of adjustable 
current ranges of the CMOS sigma-delta converters.
The key advantage of the chip integration is the digi-
talization of the measured signals in immediate vicinity 
to the sensors. Given the favorable characteristics of the 
biosensors with regard to sensitivity, selectivity, detec-
tion limit, and response time, the system enables parallel 
amperometric measurements at a very good signal-to-
noise ratio, whereas no additional noise contributions 
are picked up through connecting leads. This is crucial for 
reliable measurements in non-ideal environments with, 
e.g., freely moving animals. Multiplexing of the signals 
of the different channels helps reduce the number of con-
nections and helps minimize the dimensions of the flex-
ible cable between the animal head stage and the control 
module. Integration of the potentiostat on chip for purely 
digital wire communication as well as wireless transmis-
sion may be envisaged in future generations of the chip.
Finally, the compact control and acquisition module 
is very convenient for on-site recordings and integration 
into experimental setups. The devices are currently opti-
mized and tested with freely moving rats showing impul-
sive behavior performing the five-choice serial reaction 
time task. In semi-acute experiments, the devices have 
been implanted for recordings up to 2 weeks. The relatively 
short experimentation time is limited by the stability of 
the enzyme in vivo, which defines the functional lifetime 
of the device. In vivo stability of the sensor and the micro-
probe as well as biocompatibility and the anticipated time 
span of use are important features to be addressed in the 
near future.
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Figure 7 Recorded responses from four electrodes (A) and derived concentration profile at different time points (B) after a choline solution 
has been injected at a distance of 300 µm from biosensor electrode 4f (see Figure 4). The insert in (A) shows the geometric layout of injec-
tion point and electrode locations.
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